Your browser doesn't support javascript.
loading
The First Class of Small Molecules Potently Disrupting the YAP-TEAD Interaction by Direct Competition.
Furet, Pascal; Bordas, Vincent; Le Douget, Mickaël; Salem, Bahaa; Mesrouze, Yannick; Imbach-Weese, Patricia; Sellner, Holger; Voegtle, Markus; Soldermann, Nicolas; Chapeau, Emilie; Wartmann, Markus; Scheufler, Clemens; Fernandez, Cesar; Kallen, Joerg; Guagnano, Vito; Chène, Patrick; Schmelzle, Tobias.
Afiliación
  • Furet P; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Bordas V; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Le Douget M; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Salem B; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Mesrouze Y; Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Imbach-Weese P; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Sellner H; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Voegtle M; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Soldermann N; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Chapeau E; Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Wartmann M; Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Scheufler C; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Fernandez C; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Kallen J; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Guagnano V; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Chène P; Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
  • Schmelzle T; Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
ChemMedChem ; 17(19): e202200303, 2022 10 06.
Article en En | MEDLINE | ID: mdl-35950546
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Suiza